Hwail Pharm Co (XKRX:061250) Accounts Payable & Accrued Expense : ₩6,184 Mil (As of Mar. 2024)

View and export this data going back to 2002. Start your Free Trial

What is Hwail Pharm Co Accounts Payable & Accrued Expense?

Hwail Pharm Co's quarterly accounts payable & accrued expense increased from Sep. 2023 (₩4,818 Mil) to Dec. 2023 (₩7,101 Mil) but then declined from Dec. 2023 (₩7,101 Mil) to Mar. 2024 (₩6,184 Mil).

Hwail Pharm Co's annual accounts payable & accrued expense declined from Dec. 2021 (₩4,580 Mil) to Dec. 2022 (₩3,951 Mil) but then increased from Dec. 2022 (₩3,951 Mil) to Dec. 2023 (₩7,101 Mil).

Hwail Pharm Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for Hwail Pharm Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hwail Pharm Co Accounts Payable & Accrued Expense Chart

Hwail Pharm Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

10,836.83

4,285.54

4,579.85

3,951.34

7,101.33

Hwail Pharm Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															3,945.49	6,373.50	4,817.83	7,101.33	6,184.18

Hwail Pharm Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Hwail Pharm Co (XKRX:061250) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hwail Pharm Co Ltd (XKRX:061250) » Definitions » Accounts Payable & Accrued Expense

Traded in Other Exchanges

N/A

Address

904-7, Sangsin-Ri, Hyangnam-Eup, Hwaseong, Gyeonggi, KOR, 445-746

Website

http://www.hwail.com

Hwail Pharm Co Ltd is engaged in manufacturing and distribution of raw materials used in pharmaceutical production. Its products include antitussive expectorants, spasmolytic, stomach function modifier, anti-inflammatory, and others.

Hwail Pharm Co (XKRX:061250) Headlines

No Headlines